Alzheimer disease (AD) is a common and fatal subtype of dementia that remains a challenge to diagnose and treat. This study aimed to identify potential biomarkers that influence the prognosis of AD.
Background
Alzheimer disease (AD) is the most common subtype of dementia which is officially listed as the sixth leading cause of death worldwide. Recent estimates indicate that AD ranks third behind heart disease and cancer as the major cause of death in the elderly [1] . AD is characterized by deposits of amyloid-beta (Ab) plaques, and intracellular neurofibrillary tangles (NFT) in the neocortical and limbic regions of the brain [2, 3] . As a group of unknown primary degenerative and an irreversible progressive brain diseases, AD causes neuronal cell apoptosis and brain atrophy [4] and slowly destroys memory, cognitive ability [5, 6] and the ability of the body to perform basic bodily functions such as walking and swallowing, seriously affecting quality of life [7] . The risk factors for the onset and development of AD closely relate to oxidative stress, mitochondrial dysfunction, inflammation, glutamatergic excitotoxicity, low neurotrophic factors and neurogenesis [8] . It thus appears that AD is a complex disease for which suitable therapeutic approaches are not currently recognized. Although drug development is improving, the complexity of AD makes therapeutic approaches challenging. To improve AD therapy, a deeper understanding of the molecular mechanisms causing the disease are required [9] .
To further understand the mechanisms of AD pathogenesis, high-throughput gene expression data has been investigated and substantial progress has been made in reconstructing gene regulatory networks. Network-based approaches [10] including protein-protein interaction (PPI) networks have been applied and are informative and powerful for discovering disease mechanisms. PPI networks can be reconstructed from protein domains, gene expression data, and structure-based information [11] which serve to regulate protein activity, the scaffolding of multi-protein complexes, and enzyme-substrate interactions [12] . PPI networks are altered in many disease states [13] [14] [15] and their targeting offers hope for disease treatment. An array of studies has integrated gene expression and PPI data to identify protein complexes [16] , small subnetworks [17] , and biomarkers [18] in disease states. Transcription factor networks are also a key determinant of cell fate decisions during mammalian development and adult tissue homeostasis is disrupted in disease [19] .
The purpose of this study was to identify biomarkers that influence AD prognosis. Six gene expression profiles were obtained from the Gene Expression Omnibus (GEO) database, and 2514 differentially expressed genes (DEGs) were initially screened. Of the 379 DEGs identified, 68 were upregulated and 307 were downregulated identified through prediction analysis for microarray (PAM) algorithms that discriminate AD from normal samples. Upregulated genes were significantly enriched in histone function, beta receptor signaling, cell growth, and angiogenesis. Downregulated genes were significantly enriched in MAPK signaling, synaptic signaling, neuronal apoptosis, and Alzheimer associated pathways. A total of 32 hub genes including ENO2, CCT2, CALM2, ACACB, ATP5B, MDH1, and PPP2CA were screened based on PPI networks and module analysis. Of these hub genes, NFKBIA and ACACB were upregulated, whilst 29 genes were downregulated in AD patients. These findings reveal new AD biomarkers with prognostic and therapeutic value.
Material and Methods

Data download and preprocessing
Six sets of gene expression profiles related to AD were collected from the GEO database (https://www.ncbi.nlm.nih.gov/ geo/) including GSE1297 [20] , GSE28146 [21] , GSE4757 [22] , GSE5281 [23] , GSE48350 [24] , and GSE11882 [25] . GSE1297 was based on the GPL96 platform, whilst others were based on GPL570. The probes corresponding to multiple genes were removed and multiple probes corresponding to the genes were added. Mean expression values were then assessed. The gene sets were scored with z-score standards and extracted using shared gene sets. The genes were then integrated into large gene expression profiles. Finally, due to the batch effects of the GPL96 and GPL570 platforms, the removeBatchEffect function was employed from the limma package.
Screening of significant differentially expressed genes
Brain samples were collected from Alzheimer's disease Research Center (ADRC) brain banks for subsequent gene expression profiling. All AD patients met the Alzheimer disease and Related Disorders Association criteria for the clinical diagnosis of AD. Controls were cognitively normal healthy controls with no disease history including cardiovascular risk factors. The limma package [26] in R was used to identify significant DEGs (fold change >1.2; P<0.05).
Establishment of the PAM model
PAM algorithms (http://www-stat.stanford.edu/tibs/PAM/index.html) were used to identify potential biomarkers with diagnostic value in AD. The centroid methodology [27] was employed to obtain accurate classifications and depict each gene class. The sorting approach can shrink each class centroid to an overall centroid based on the threshold values to solve data classification difficulties. Moreover, 10-fold crossvalidations were performed to guarantee forecasting accuracy. For the aforementioned gene integration profiles, we used limma analysis to build the PAM model and identify potential biomarkers of AD.
Gene Set enrichment analysis
The function of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the potential biomarkers was analyzed by Database for Annotation, Visualization and Integrated Discovery.(DAVID) (https://david.ncifcrf.gov/, 6.7 version) with Benjamini P<0.05. Subsequent studies involving the significant functional enrichment of GO and KEGG analysis were used in the analysis. 
Gene Set Enrichment Analysis (GSEA) enrichment analysis
We used C2 curated genes as background gene sets using the MsigDB database (http://software.broadinstitute.org/gsea/msigdb/, version 6.2). The screening of upregulated and downregulated gene sets was performed using GSEA enrichment analysis, specific parameters were as follows: Establishment of the PPI network "Multiple Protein" functional modules of the String database (http://string-db.org/, v10.5) were used to construct the PPI network which was further visualized using Cytoscape (version 3.6.1) software. Moreover, we analyzed the betweenness, tightness, degree and distribution of hub genes in the PPI network using the igraph R package. We searched for whole functional modules through the fastest greedy algorithm and analyzed GO and KEGG pathway enrichment analysis of the genes in these modules. Hub genes in the PPI network were identified and the proteins of these hub genes were further characterized based on degree size of the network.
Transcription factor analysis
Transcription factor gene data of the RegNetwork database (http://regnetworkweb.org/) was used to characterize the transcription factor regulatory networks associated with the target genes. The RegNetwork describes transcription factor to genes from the perspective of TransFac, TRED and JASPAR database resources. The RegNetwork describes a more comprehensive transcription factor regulation network. RegNetwork describes transcriptional regulation between transcription factor and target genes from the 3 database resources of TransFac, TRED, and JASPAR, and the RegNetwork's transcription factor regulation network is more comprehensive. Amongst them, the RegNetwork database contains 149 841 transcriptional regulations between transcription factor and target gene regulatory relationships in humans. Target and hub genes were mapped into the transcription factor regulatory network separately to obtain each transcription factor regulatory network which were visualized using Cytoscape. Furthermore, transcription 
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Results
Data downloads and preprocessing
Six sets of AD gene expression profiles were download from the GEO database. The PAM model was built and designed and is presented in Figure 1 .
Screening of significant differentially expressed genes
We downloaded the gene expression profiles of AD including GSE1297, GSE28146, GSE4757, GSE5281, GSE48350, and GSE11882 (Table 1 ). For each set of expression profiles, probes corresponding to the multiple genes were respectively deleted, whilst for multiple probes corresponding to the same gene, the mean expression values of the probes were taken as the expression values of the genes. Next, z-score standardization was performed for the 6 expression profiles. A total of 12 399 shared genes from 6 expression profiles were extracted, and 6 sets of expression profiles were integrated in large gene expression profiles which contained 12 399 genes and 668 samples. As the origin of the expression profiles were from GPL96 and GPL570 platforms, the platform differences were regarded as batch effects, and the data was further processed by the removeBatchEffect of the limma package. In Figure 2 , the bar graph corresponds to the number of samples in each data set and each black solid origin corresponds to the corresponding GEO data sets. The lines between the solid origins explain that the same sample is present in both GSE11882 and GSE48350 datasets. GSE48350 contained 173 samples of GSE11882. Finally, we analyzed GSE1297, GSE28146, GSE4757, GSE5281, and GSE48350 datasets that included 12 399 genes, and 495 samples (394 AD and 101 normal samples). For these samples, the demographic characteristics of the patients (sex, age, stage, etc.) are shown in Table 2 . A total of 2514 DEGs (fold change >1.2; P<0.05) were obtained through the expression profiles of the limma package. Amongst them, the DEGs contained 2446 downregulated genes and 68 upregulated genes ( Figure 3A, 3B) .
Establishment of the PAM model
The PAM algorithm was used to identify potential biomarkers with diagnostic value in AD. Objects were trained in the pamr package of R to ensure minimal errors between cross-validation sets and test sets using 10-fold cross-validation. As shown in Figure 4A , the threshold was selected as 2.65 and we identified a total of 379 significant DEGs. As shown in Figure 4B , there were 307 downregulated genes and 68 upregulated genes. These DEGs represented potential biomarkers of AD.
Gene Set enrichment analysis
Both upregulated and downregulated genes were subjected to GO and KEGG pathway enrichment analysis using DAVID (https://david.ncifcrf.gov/, version 6.7) (Benjamini P<0.05). Amongst them, we identified 307 downregulated genes that were significantly enriched in MAPK signaling pathway, synaptic GO: 0006810-transport GO: 0021766-hippocampus development GO: 0019674-NAD metabolic process GO: 0090383-phagosome acidi cation GO: 0006107-oxaloacetete metabolic process GO: 0060071-Wnt signaling pathway, planar cell polarity pathway GO: 0050852-T cell receptor signaling pathway GO: 0002479-antigien processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO: 0000086-G2/M transition of mitotic cell cycle GO: 0043488-regulation if mRNA stability GO: 0033572-transferrin transport GO: 0006096-glycolytie process GO: 0006521-regulation of cellular amino acid metabolic process GO: 0015991-ATP hydrolysis coupled proton transport GO: 0006091-gluconeogenesis GO: 0002223-stimulatory C-typr lectin receptor signaling pathway GO: 0051437-positive regulation of ubiquitin-protein ligase activity incloved in regulation of mitotic cell cycle GO: 0015992-proton transport GO: 0038061-NIK/NF-kappaB signaling GO: 0038095-Fe-epsilon receptor signaling pathway GO: 0010801-negative of peptidyl-threonine phosphory lation GO: 0030207-chondroitin sulfate catabolic process GO: 0030208-dermatan sulfate biosynthetic process GO: 0007179-transforming growth factor beta receptor signaling pathway GO: 0043486-histone exehange GO: response to muramyl dipeptide GO: 0016049-cell growth GO: 0001570-vasculogenesis signaling, neuronal projection development, neuronal apoptosis, protein folding, and Alzheimer-related pathways ( Figure 5A, 5B) . The 68 upregulated genes were significantly enriched in cell growth, histone modifications and angiogenesis ( Figure 5C ).
GSEA enrichment analysis
We selected C2 curated gene sets from the MsigDB database (http://software.broadinstitute.org/gsea/msigdb/, version 6.2) as background gene sets. The upregulated and downregulated genes were analyzed by GSEA enrichment using the parameters described in the materials and methods. Since the upregulated gene sets contained only 68 genes, the GSEA requires that the input gene sets are greater than 100. We performed GSEA analysis on the 307 downregulated genes and imprints in the GSEA display. At P-values <0.05, the downregulated genes were significantly enriched in pathways including: MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP, CHOW_RASSF1_TARGETS_DN, YANG_BREAST_CANCER_ESR1_BULK_UP, APPIERTO_RESPONSE_TO_FENRETINIDE_DN, KEGG_CYSTEINE_AND_METHIONINE_METABOLISM, MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP and VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN. The GSEA display results are shown in Figure 6 .
PPI network analysis
"Multiple Protein" functional modules of the String database were used to construct the PPI network of 379 significant DEGs ( Figure 7A ), and the network contained 281 nodes and 1177 edges. For the PPI network of the 379 significant DEGs, we used the igraph R package to calculate the topological properties of the network including the betweenness and tightness of the network, which were 270.6948 and 0.0006465125, respectively. The genes with a degree greater than or equal to 16 were regarded as hub genes ( Figure 7B ). The maximum degree of 36 was for ENO2 and others included CCT2, CALM2, ACACB, ATP5B, MDH1, PPP2CA, PSMD14, ATP5C1, LDHA, CCT4, COPS5, TXN, PGK1, NDUFA4, ACTR10, IMMT, ATP5F1, NDUFAB1, CUL1, PSMB7, SKP1, MTHFD1, TUBA4A, PSMA5, TUBA1B, TUBA1C, HINT1, NME1, PSMA1, TUBB4B, and NFKBIA. Of the 32 hub genes, NFKBIA and ACACB were upregulated and 29 genes were downregulated in AD patients. Figure 7C shows the degree distribution of the genes in the network. Figure 7D shows the hub scores of the 281 genes, where black points indicate hub scores of the non-hub genes and red scores indicate hub scores of the hub genes. The hub scores for the hub nodes were significantly higher. Document verification of these genes is shown in Table 3 .
Using functional annotation of the 32 hub genes using DAVID, the genes were enriched in the regulation of telomerase activity and function, carbon metabolism, and TGF-beta signaling. As shown in Figure 7E and 7F, the functions of GO and KEGG of the 32 hub genes were correctly displayed.
For the PPI network, we identified 9 functional modules ( Figure 8A ). Amongst them, the largest number of genes focused on the first, second, and third modules which contained 55, 67, and 40 genes, respectively. The genes in the 3 modules are enriched and analyzed. Figure 8B and 8C show that the first module mainly involved protein folding, glycolysis, metabolic pathways, and amino acid synthesis. Figure 8D and 8E showed that the second module involved the regulation of neuronal apoptosis, neurotransmitter secretion, cell histamine responses and other important functions. Figure 8F and 8G show that the third module was enriched for important functions such as protein catabolism, protein repair, TGF-signaling pathway and cell cycle regulation.
Transcription factor analysis
Data were downloaded from the RegNetwork database (http:// regnetworkweb.org/) to obtain regulatory data for transcriptional factors and genes. The 379 most significant DEGs were then mapped to the network. Finally, a transcription factor 
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This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) e919249-10 regulatory network containing 753 points and 3174 edges were obtained ( Figure 9A ) which contained 404 transcription factors and 359 regulated genes. In Figure 9A , the red triangles indicate transcription factors; green circles indicate genes; and arrows indicate the transcriptional regulations between transcription factor and target gene regulation. Through DAVID's functional enrichment analysis, we found 404 transcription factors that regulate neuronal apoptosis, neuronal differentiation, calcineurin-NFAT signaling cascades, protein complex assembly, cellular insulin responses, Ras protein signaling, Toll-like receptor signaling pathways, T cell signaling pathways, Huntington's disease-related pathways, and DNA replication ( Figure 9B, 9C) .
Considering the functions of the 32 hub genes in previous PPI networks, we characterized the post-transcriptional regulatory networks of the 32 genes and obtained regulatory relationships between transcription factor and the hub genes. As shown in Figure 9D , for these 32 hub genes, 31 (~96.875%) were regulated by 12 transcription factors. These 12 transcription factors are associated with protein transcription, drug responses, cell apoptosis, ErbB signaling, cell proliferation, and Jak-STAT signaling (Figure 9E, 9F ). 
Discussion
Dementia represents a broad category of brain diseases that cause the loss of cognitive functioning including thinking, remembering, reasoning, and behavioral abilities that interfere with daily life activities [27] . AD is the most common subtype of dementia that contributes to 60-70% of cases [28] and ultimately leads to death [29] [30] [31] . To systematically understand the pathogenesis of AD and provide a diagnosis we integrated 6 gene expression profiles of the GEO database of AD, including Go enrichment of module 2 0.00E+00 1.00E-02 2.00E-02 3.00E-02 4.00E-02 5.00E-02 6.0E-02 GO: 0010764~neuron migration go: 0051560~mitochondrial calcium ion homeostasis GO: 0010880~regulation of relase of sequestered calcium ion into cytosol by sarcoplasmic reticulum GO: 0047469~vesicle transport along microtubule GO: 0007097~nuclera migration GO: 0050885~neuromuscular process controlling balance GO: 0007628~adult walking behavior GO: 0007269~neurotransmitter secretion GO: 0007017~microtubule-based process p value Go enrichment of module 3 0.00E+00 1.00E-02 2.00E-02 3.00E-02 4.00E-02 5.00E-02 6.00E-02 GO: 0001731~formation of translation preinitiation complex GO: 0006301~postreplication repair GO: 0006511~ubiquitin-dependent protein catabolic process GO: 0051092~positive regulation of NF-kappaB transcription factor activity GO:0000729~DNA double-strand break processing GO: 0043161~proteasome-mediated ubiquitin-dependent protein catabolic process GO: 0006413~translational initiation GO: 0031146~SCF-dependent proteosomal ubiquitin-dependent protein catabolic... GO 
